Objective: Many patients with advanced lung cancer invading the airway require only palliation; however, induction chemotherapy and surgery may sometimes be considered. Preliminary endoscopic palliation may improve quality of life and functional status, allows better evaluation of tumor extension and contributes to prevent infectious complications. We reviewed our experience with preliminary laser treatment, induction chemotherapy and surgical resection in patients with lung cancer invading the airway. Methods: Twenty-one patients with stage IIIA and IIIB lung cancer presenting with an 80% unilateral airway obstruction were treated with laser resection, induction chemotherapy and surgery. Spirometry, arterial blood gasanalysis, quality of life (QLQ±C30 score) and performance status were recorded before and after laser treatment and after chemotherapy. Complications during chemotherapy, surgical morbidity and mortality, and survival were also recorded. Results: No complications were observed after endoscopic treatment. FEV 1 signi®cantly improved from 1.4^0.4 l/s to 2.2^0.7 l/s, as well as FVC (from 2^0.5 to 3.1^0.8 l), and remained stable after chemotherapy. The QLQ±C30 score signi®cantly improved after laser treatment (from 45^4.8 to 31^2.5) as well as the Karnofsky status (from 76^5 to 90). One patient developed pneumonia during induction chemotherapy. Three patients were not operated on. We performed ®ve pneumonectomies (one right tracheal sleeve pneumonectomy) and 13 lobectomies (®ve associated to a bronchial sleeve resection). One patient (5.5%) died after the operation. Four patients experienced minor postoperative complications. Three-year survival after the operation was 52%. Conclusions: Preliminary endoscopic palliation of lung cancer invading the airway is feasible, improves evaluation and staging, helps to reduce the incidence of complications during induction chemotherapy without increasing surgical morbidity and mortality. q
Introduction
Primary surgical resection is actually considered, whenever feasible, the gold standard for lung cancer treatment; however, only 30±40% of patients survive more than 5 years and almost 95% of the whole population requires palliative treatment at a certain point of their disease history. Thirty percent of lung cancers cause partial or complete obstruction of the airway with consequent respiratory distress, bleeding and infection [1] . Many patients require palliation only; however, in selected cases, induction chemotherapy and surgery may be considered. Endoscopic management should play an important role since conventional treatment with chemotherapy/radiotherapy alone as performed in the past [2, 3] yielded unsatisfactory immediate restoration of a viable airway; Nd:YAG laser, intraluminal brachitherapy and stenting allow better results in terms of patency of the airway and immediate palliation of symptoms [4] . Preliminary endoscopic laser resection contributes to improve quality of life and functional status, allows better evaluation of tumor extension and staging, and contributes to prevent infectious complications, especially when chemotherapy is to be administered.
We reviewed our experience with preliminary endoscopic laser treatment, induction chemotherapy and surgical resection in patients with lung cancer invading the airway. presenting with an 80% unilateral airway obstruction where initially treated with Nd:YAG laser resection of the endobronchial component of the tumor. Fifteen patients were males and six were females; the mean age was 59^13 years (45±75 years). At presentation hemoptysis was present in ten patients (48%), cough in 11 (52%), fever and signs of infection in seven (33%), dyspnea under effort in six (29%), dyspnea at rest in three (14%) and pain in four (19%). Histology of the tumor was obtained by direct biopsy during endoscopy in all patients. Fourteen patients had squamous cell carcinoma (67%) and seven (33%) had adenocarcinoma. In 15 patients the primary tumor was located in the upper lobe, in ®ve in the inferior lobe and in one in the middle lobe. Six patients had complete atelectasis and seven had lobar atelectasis; all the other patients had an 80% obstruction of the airway without atelectasis. After laser treatment and restoration of a viable airway induction chemotherapy and subsequent surgical resection were considered. Mediastinoscopy was performed in all patients to stage the mediastinal lymph nodes before induction chemotherapy. Before chemotherapy three patients (14%) had T 2 N 2 lung cancer, 9 (43%) T 3 N 2 , 2 (9.5%) T 4 N 0 , 2 (9.5%) T 4 N 1 , 5 (24%) T 4 N 2 . A cisplatin based induction regimen was administered and patients were subsequently reassessed. Spirometry, arterial blood gasanalisis and Karnofsky performance status were recorded before and after laser treatment and after chemotherapy. Also quality of life was measured at the three different steps using the EORTC QLQ-C30 questionnaire [5] ; this is a 30-item questionnaire composed of multi-item scales and single items that re¯ect the multidimensionality of the quality of life construct [6, 7] . It incorporates ®ve functional scales (physical, role, cognitive, emotional and social), three symptom scales (fatigue, pain, and nausea and vomiting) and a global health and quality-of life scale. The remaining single items assess additional symptoms commonly reported by cancer patients as well as the perceived ®nancial impact of the disease and treatment.
Patients and methods

Twenty
Complications during chemotherapy, type of surgical resection, morbidity and mortality after surgery, and survival were also recorded. The statistical analysis was performed with the Student t-test.
Results
No complications were observed during and after endoscopic Nd:YAG laser resection. FEV 1 signi®cantly improved after laser treatment and remained stable after chemotherapy (1.2^0.7 l/s pre laser, 2.2^0.7 l/s post laser, 2.2^0.9 post chemio; P , 0:001), as well as FVC (2^0.5 l pre laser, 3.1^0.8 l post laser, 3^0.6 l post chemio; P , 0:001) and PaO 2 (69^8 mmHg pre laser, 82^5 mmHg post laser, 81^5 mmHg post chemio; P , 0:001). Two patients requiring supplemental O 2 before laser resection were completely weaned after the endoscopic procedure. Preliminary laser resection contributed to palliate hemoptysis, dyspnea, cough and infection in all patients presenting with these symptoms. The Karnofsky status (76^5, 90^5 and 92^5 respectively; P , 0:001) and the global QLQ-C30 score (45^5, 31^2.5 and 30^3 respectively; P , 0:001) signi®cantly improved after laser treatment and remained stable after chemotherapy. Also the functional scales and the symptoms scales were signi®cantly improved after laser treatment, as well as the dyspnea and global quality of life scales (Table 1) .
One patient developed pneumonia during induction chemotherapy. Three patients were not operated on since they showed a progression of the disease during induction chemotherapy with distant metastases (M 1 ) and N 3 disease.
At operation we performed ®ve pneumonectomies (one tracheal sleeve resection) and 13 lobectomies (®ve associated to a bronchial sleeve resection); one patient (5.5%) was staged T 0 N 0 (T 4 N 1 pre chemio) nine (50%) T 2 N 1 , three (17%) T 3 N 1 , two (11%) T 1 N 2 , two (11%) T 3 N 2 , one (5.5%) T 4 N 0 . One patient (5.5%) died after right tracheal sleeve pneumonectomy: the postoperative course was complicated by a dehiscence of the tracheal anastomosis, sepsis and multiple organ failure. Four patients experienced minor postoperative complications (arrhythmia: one; wound infection: one; prolonged air leaks: two). Survival at one and three years for all patients included in the study was 71 and 46% respectively; the 1 and 3 year survival for patients receiving surgical resection was 83 and 52% (Fig. 1 ).
Discussion
Stage IIIA and IIIB lung cancer may present with symptoms of airway obstruction due to either direct in®ltration or extrinsic compression; at this stage, primary surgery is often not feasible both for technical and oncological reasons; however, several studies demonstrated that preoperative chemotherapy alone or in combination with radiotherapy may improve resectability and survival [8±11]. Partial or complete airway obstruction may contribute to deteriorate the functional and clinical status of the patient and also staging may be dif®cult due to lung atelectasis. Restoration of a viable airway is mandatory to improve functional parameters, stage the tumor and establish which patient is really unresectable or could undergo either primary surgery or be included in an induction therapy protocol. In this setting, endoscopic treatment is obviously palliative and is sometimes required in emergency [12±14]; it may be of particular value to provide time to assess the disease and allow subsequent treatment to be given electively [15±17]. Only few reports stress the importance of a combined approach [15± 19]; this has been proposed for low grade malignant tracheal and bronchial tumors or for primary carcinoma of the central airway (trachea, carina, origin of the main stem bronchi) [16, 17] in this setting surgery can be performed immediately after laser therapy, when the potential life threatening situation has been treated and the patient is stable. Lung cancer implies different considerations; in this setting, endobronchial management may play an important role; in fact, conventional treatment with chemo-radiotherapy was usually administered in the past [2, 3] with unsatisfactory results on airway patency and also mechanical resection [20] allows less stable results [4] . Laser resection enables an immediate restoration of a viable airway with better medium term palliation, probably in relation to the cytocide effect deeply within the tumor.
In case induction chemotherapy and surgery are deemed possible after laser treatment, computed tomography of the chest should be repeated for a reliable assessment of the extension of the primary tumor and ilo-mediastinal lymph nodes. Invasive staging for N 2 ±N 3 disease (mediastinoscopy) is mandatory and also thoracoscopy may be considered to evaluate T 3 ±T 4 parameters [21] . The tumor could be downstaged by aeration of the atelectatic lung and consequent better de®nition of tumor size and local invasion; it could also be assessed correctly the site of origin of endobronchial invasion; the latter is usually more distal than ®rst glance preoperative evaluation since the endobronchial component tend to migrate proximally towards the carina. All our patients were considered inoperable at other centers either for functional reasons or because extension of the primary tumor and mediastinal involvement or a combination of those situations. In many cases pneumonectomy was considered the only possible resection and it was deemed unfeasible for functional or technical reasons; after laser resection and induction chemotherapy a simple lobectomy or a bronchial sleeve resection could often be performed [22] with lower operative risk, better early and long term functional results and similar radicality from the oncological stand point.
Preliminary laser resection ameliorates the performance status and quality of life with a consequent improved tolerance of induction chemotherapy: almost all our patients could complete the protocol without major complications; their performance status, functional parameters and quality of life improved after endoscopic palliation and remained stable during chemotherapy. Pulmonary rehabilitation and an adequate medical treatment should be enclosed in the schedule.
Preliminary endoscopic laser treatment and restoration of a viable airway is feasible, improves the clinical status and allows accurate staging of patients with lung cancer without increasing postoperative morbidity and mortality. The potentiality of the combined approach should be considered to enlarge the group of patients to be treated with induction chemotherapy. 
